Skip to Content

Lumason Approval History

  • FDA approved: Yes (First approved October 10th, 2014)
  • Brand name: Lumason
  • Generic name: sulfur hexafluoride lipid microsphere
  • Dosage form: Injectable Suspension
  • Company: Bracco Diagnostics Inc.
  • Treatment for: Diagnosis and Investigation

Lumason (sulfur hexafluoride lipid microsphere) is a contrast agent used for ultrasound imaging.

Development History and FDA Approval Process for Lumason

DateArticle
Oct 10, 2014Approval FDA Approves Lumason Ultrasound Imaging Agent

Disclaimer: Every effort has been made to ensure that the information provided here is accurate, up-to-date and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. This information has been compiled for use by healthcare practitioners and consumers in the United States. The absence of a warning for a given drug or combination thereof in no way should be construed to indicate that the drug or combination is safe, effective or appropriate for any given patient. If you have questions about the substances you are taking, check with your doctor, nurse or pharmacist.

Hide